Skip to content

CLLS

Cellectis SA

NASDAQ · Healthcare · Biotechnology · FR

$0.91
−12.40%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
0.81x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
2.23x
Price / sales
1.62x
Price / cash flow
-2.19x

Enterprise value

Enterprise value
$9.5M
EV / sales
0.17x
EV / EBITDA
-0.17x
EV / EBIT
-0.15x
Market cap
$91.8M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026